Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.

Provided By GlobeNewswire

Last update: Oct 2, 2024

Name change to "Climb Bio" marks the Company’s transition and focus on developing treatments for immune-mediated diseases

Climb Bio will begin trading on Nasdaq under the trading symbol "CLYM" effective October 3rd